Cells to Surgery Quiz: January 2018

J Invest Dermatol. 2018 Jan;138(1):e11. doi: 10.1016/j.jid.2017.11.010.

Authors

Parteek Singla¹, Jessica B Dietert¹, Eva A Hurst²

Affiliations

¹ Division of Dermatology, Washington University in St. Louis, Saint Louis, MO, USA.
² Division of Dermatology, Washington University in St. Louis, Saint Louis, MO, USA. Electronic address: ehurst@dom.wustl.edu.

PMID: 29273151
DOI: 10.1016/j.jid.2017.11.010

No abstract available

MeSH terms

Administration, Cutaneous
Arm
Arm Injuries / complications*
Bleomycin / pharmacology
Bleomycin / therapeutic use
Botulinum Toxins, Type A / pharmacology
Botulinum Toxins, Type A / therapeutic use
Cicatrix, Hypertrophic / diagnosis*
Cicatrix, Hypertrophic / drug therapy
Cicatrix, Hypertrophic / etiology
Cicatrix, Hypertrophic / pathology
Dermatologic Agents / pharmacology
Dermatologic Agents / therapeutic use*
Fingolimod Hydrochloride / pharmacology
Fingolimod Hydrochloride / therapeutic use
Fluorouracil / pharmacology
Fluorouracil / therapeutic use
Humans
Imiquimod / pharmacology
Imiquimod / therapeutic use
Signal Transduction / drug effects
Skin / drug effects*
Skin / injuries
Skin / pathology

Substances

Dermatologic Agents
Bleomycin
Botulinum Toxins, Type A
Fingolimod Hydrochloride
Imiquimod
Fluorouracil